Skip to main content
SLXN logo

SLXN · Silexion Therapeutics Corp · Executive Compensation

Track SLXN — free
$1.37 -0.14 (-9.00%)
Market Cap
$974,292
Shares
649,528
Volume · Nov 20 8338 Avg daily vol (7 sessions) 84.05K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024
Executive Total
Ilan Hadar $1,540,628
Dr. Mitchell Shirvan $1,301,490
Mirit Horenshtein Hadar $770,090
Fiscal 2023
Executive Total
Ilan Hadar $253,614
Dr. Mitchell Shirvan $206,800
Mirit Horenshtein Hadar $26,238

Executive changes

Person Change Filed
Amnon Peled
“Professor Peled’s resignation did not arise or result from any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.”
Resigned 2026-07-31
Ilan Levin Terminated 2026-03-25
Amnon Peled Appointed 2024-12-10
Ilan Shiloah
“Mr. Shiloah’s decision to resign stemmed from competing demands on his time, and did not arise or result from any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
Resigned 2024-09-19
Shlomo Noy Appointed 2024-08-21
Ilan Shiloah Appointed 2024-08-21
Ilan Levin Appointed 2024-08-21
Avner Lushi Appointed 2024-08-21
Ruth Alon Appointed 2024-08-21
Dror Abramov Appointed 2024-08-21
Ilan Hadar Appointed 2024-08-21
Mitchell Shirvan Appointed 2024-08-21
Mirit Horenshtein Hadar Appointed 2024-08-21
Ilan Hadar Appointed 2024-08-21

Leadership

Key facts CIK 2022416 CUSIP G1281K148 13F (30d) 13 filings 11 filers Visit website Investor relations